Alliance Pharma (LON:APH) Sets New 52-Week High – Here’s What Happened

Alliance Pharma plc (LON:APH)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 61.50 ($0.76) and last traded at GBX 61.20 ($0.75), with a volume of 8782805 shares changing hands. The stock had previously closed at GBX 61.10 ($0.75).

Alliance Pharma Price Performance

The firm has a market cap of £330.83 million, a P/E ratio of -1,020.00, a P/E/G ratio of 1.04 and a beta of 0.67. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42. The company has a fifty day moving average of GBX 48.48 and a 200-day moving average of GBX 43.21.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.